Unigene Laboratories

Unigene Laboratories, Inc. is a biopharmaceutical company engaged in the research, production and delivery of valuable therapeutic peptide hormones. The Company has patented manufacturing technology for producing amidated peptides cost-effectively and in quantities sufficient to support the worldwide commercialization of peptide therapeutics for oral delivery. The Company has also patented novel oral drug delivery technology for peptide hormones. Unigene's first commercial products will be different formulations of calcitonin for the treatment of osteoporosis and other indications. The Company has launched its injectable calcitonin product in the European Union and is developing a nasal calcitonin product, as well as oral formulations of calcitonin and other peptides.

Contact Details: 110 Little Falls Road Fairfield NJ 07004 United States of America Tel: (973)882-0860 Fax: (973)882-8277 Email: jgilligan@unigene.com WWW: www.unigene.com/

Loading...

Recent Publications by Unigene Laboratories:
Calcitonin for osteoporosis and bone pain. Calcitonin has been approved for the treatment of osteoporosis and other...	3rd February, 2004	Unigene Laboratories Inc., 110 Little Falls Road, Fairfield, New Jersey	Curr Pharm Des. 2003;9(32):2659-76.
Production of salmon calcitonin by direct expression of a glycine-extended precursor in Escherichia coli. The export of heterologous products into the conditioned medium of an...	9th May, 2003	Unigene Laboratories, Inc., 110 Little Falls Road, Fairfield, NJ 07004,	Protein Expr Purif. 2002 Nov;26(2):249-59.

BioNews Results for Unigene Laboratories:
StockProfiler.US: Stock Watch: UGNE, PNRC, TGLN	Individual.com:  Nov 10 2009 6:14PM Matching: unigene laboratories
Unigene Announces Financial Results for Third Quarter 2009	Freshnews.com:  Nov 9 2009 10:23PM Matching: unigene laboratories
Unigene Announces Financial Results for Third Quarter 2009	Genetic Engineering News:  Nov 9 2009 10:34PM Matching: unigene laboratories
Thewallstreetleader.com: HearAtLast Holdings, Inc. & Unigene Laboratories, Inc.	Individual.com:  Nov 5 2009 11:58PM Matching: unigene laboratories
Unigene to Release Third Quarter 2009 Results and Host Conference Call	Individual.com:  Nov 5 2009 7:34AM Matching: unigene laboratories
Promote your company here: BioNewsCast - Press Release Distribution	→View more Unigene Laboratories news.

Unigene Laboratories Clinical Trials:
A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women

Unigene Laboratories Patents:
US Patent No.	Title
7553655	Bacterial host cell for the direct expression of peptides
4708934	.alpha.-amidation enzyme
5789234	Expression systems for amidating enzyme
5912014	Oral salmon calcitonin pharmaceutical products
6086918	Oral peptide pharmaceutical products
→View more Unigene Laboratories patents.

Unigene Laboratories (UGNE.OB) Financial information Links from Barchart
UGNE.OB Quote from from Barchart.com
UGNE.OB Chart from from Barchart.com
UGNE.OB Profile from from Barchart.com
UGNE.OB Opinion from from Barchart.com
→View more Unigene Laboratories finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 596 times since April 2007, the link to the organisation's website has been followed 92 times

Recent Search Terms used to find this page: unigene pharmacy | .

Search for more companies in Fairfield

Search for more companies in NJ

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Unigene Laboratories